Clinical Trials on Abdominal CT Imaging Performed as Standard of Care in Australia
Total 0 results
Nothing found
Sponsors and Collaborators
- IN-JET APS
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- JMI Laboratories
- Fogarty International Center of the National Institute of Health
- Janssen (China) Research & Development Center
- UZ Leuven, campus Pellenberg (Belgium)
- Hazelden Betty Ford Foundation
- The Fred Hollows Foundation, Australia
- Familien Hede Nielsens Fond
- Physip S.A
- Prof. Jacques SCHRENZEL
- Hospital Samaritano Paulista
- Custom Pharmaceuticals Limited
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- Pedro Gamito
- Nestlé Health Science Belgium
- Stannah Stairlifts
- Advanced Life Solutions
- Markham Stouffville Hospital
- Dr. Praveen B.H
- View Full List
Medical Conditions
- Skull Base Neoplasms
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Gullian Barre Syndrome
- Closure; Foramen Ovale
- Endocarditis Infective
- Psoriasis, Arthritic
- Ewing's Family Tumors
- Pulmonary Adenocarcinoma
- Fracture Dislocation of Cervical Spine
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Childhood Langerhans Cell Histiocytosis
- Painless Hysteroscopy
- Chlamydophila Infections
- Epidemic Hemorrhagic Fever
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Predictors of Atrial Fibrillation Recurrences
- Tay-Sachs Disease Ganglioside
- Fetus or Neonate Affected by External Version Before Labor
- Spine Surgeries
- Multisystem Proteinopathy
- View Full List
Drug Interventions
- Semapimod
- Esomeprazole 40mg before
- Redifferentiation with retinoid acid
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Glimepiride
- Adapalene Gel 0.3%
- High dose pantoprazole infusion
- Qingkailing injection 40 ml
- Cereport
- Adriamycin
- Palliative care group first-line scheme
- Vehicle
- EFV +TVA
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Estradiol+Drospirenone
- Chemotherapeutic Agent
- Neihulizumab
- Azelastine hydrochloride (BAYR9258)
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Colombia
- Contract Research Organizations in Denmark
- Contract Research Organizations in France
- Contract Research Organizations in Germany
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Qatar
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Ukraine
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in Uzbekistan
- CRO list by country